berdazimer (Zelsuvmi)
Jump to navigation
Jump to search
Indications
- at home treatment of molluscum contagiosum (FDA-approved Jan 2024)[1]
* expected to be available in the U.S. by the 2nd half of 2024
Dosage
Adverse effects
- application site reactions[1]
Mechanism of action
- gel contains a nitric oxide-releasing agent with antiviral activity
- precise mechanism of action unknown[1]
* effects not spectacular
- 30% of patients with complete or near complete response
- 10-15% improvement over control group[1]